末梢血CD34陽性細胞採取による血管再生療法(再生医療とアフェレシス)

概要

論文の詳細を見る
A method to utilize multi-potent stem cells in the peripheral blood as a source of angiogenesis therapy instead of bone marrow cells is developed. It is the same method used to obtain effective cells from blood as that used for autologous peripheral blood stem cell harvesting for hematological malignancies. After the direct inoculation of harvested cells at multiple points in intramuscular tissue, more than 70%of the inoculated hands or legs of ASO patients experienced areduction of severe pain and improved blood flow. Purified CD 34-positive cells were proved to be a source of micro-vessels. No serious adverse effects were observed except one heart attack experienced by an ischemic heart disease patient.
日本アフェレシス学会の論文
2006-10-31